Overtube¸¦ ÀÌ¿ëÇÑ ½ÄµµÁ¤¸Æ·ù °áÂû¼ú ÈÄ ¹ß»ýÇÑ ½ÄµµÃµ°ø°ú Áö¿¬¼º ÇÕº´ÁõÀ¸·Î ³ªÅ¸³­ Á¾°Ýµ¿¿°ÀÇ Ä¡·á
Overtube-related Delayed Esophageal Perforation with Mediastinitis

´ëÇѼÒÈ­±âÇÐȸÁö 2014³â 64±Ç 4È£ p.224 ~ p.228

±è¼±¿õ(Kim Sun-Woong) - °Ç±¹´ëÇб³ ÀÇ°ú´ëÇÐ °Ç±¹´ëÇб³º´¿ø ³»°úÇб³½Ç
ÀÌÀ±Á¤(Lee Yoon-Jeong) - °Ç±¹´ëÇб³ ÀÇ°ú´ëÇÐ °Ç±¹´ëÇб³º´¿ø ³»°úÇб³½Ç
±è¼öÁ¤(Kim Soo-Jung) - °Ç±¹´ëÇб³ ÀÇ°ú´ëÇÐ °Ç±¹´ëÇб³º´¿ø ³»°úÇб³½Ç
ÀÌ°æ¾ð(Lee Kyung-Ann) - °Ç±¹´ëÇб³ ÀÇ°ú´ëÇÐ °Ç±¹´ëÇб³º´¿ø ³»°úÇб³½Ç
±è¾Æ¶õ(Kim Ah-Ran) - °Ç±¹´ëÇб³ ÀÇ°ú´ëÇÐ °Ç±¹´ëÇб³º´¿ø ³»°úÇб³½Ç
¹Ú»ó¿ì(Park Sang-Woo) - °Ç±¹´ëÇб³ ÀÇ°ú´ëÇÐ °Ç±¹´ëÇб³º´¿ø ¿µ»óÀÇÇаú
ÃÖ¿øÇõ(Choe Won-Hyeok) - °Ç±¹´ëÇб³ ÀÇ°ú´ëÇÐ °Ç±¹´ëÇб³º´¿ø ³»°úÇб³½Ç
½ÉÂù¼·(Shim Chan-Sup) - °Ç±¹´ëÇб³ ÀÇ°ú´ëÇÐ °Ç±¹´ëÇб³º´¿ø ³»°úÇб³½Ç

Abstract

Overtube provides a conduit for the passage of endoscope into the digestive tract. Esophageal perforation with mediastinitis is a rare overtube-related complication. Until now, no reports have been published regarding the esophageal perforation which developed many months after the original procedure using the overtube. A 56-year-old female visited our hospital complaining of chest pain and back pain that began 14 days ago. The patient underwent esophageal variceal ligation using the overtube 12 months earlier. She was diagnosed with esophageal perforation with mediastinitis which extended to intervertebral and epidural space. The cause of this condition was considered to have been related to the use of overtube. Management of delayed perforation remains controversial. Although surgical management might be the preferred mode of treatment, she underwent local N-butyl 2-cyanoacrylate injection therapy and temporary stent therapy with antibiotics due to high operative risk. Herein, we report a case of overtube-related delayed esophageal perforation with mediastinitis that was successfully treated by nonoperative management.

Å°¿öµå

Esophageal perforation, Mediastinitis, Overtube, Stents
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå